Literature DB >> 12489991

Defects in pre-mRNA processing as causes of and predisposition to diseases.

Peter Stoilov1, Eran Meshorer, Marieta Gencheva, David Glick, Hermona Soreq, Stefan Stamm.   

Abstract

Humans possess a surprisingly low number of genes and intensively use pre-mRNA splicing to achieve the high molecular complexity needed to sustain normal body functions and facilitate responses to altered conditions. Because hundreds of thousands of proteins are generated by 25,000 to 40,000 genes, pre-mRNA processing events are highly important for the regulation of human gene expression. Both inherited and acquired defects in pre-mRNA processing are increasingly recognized as causes of human diseases, and almost all pre-mRNA processing events are controlled by a combination of protein factors. This makes defects in these processes likely candidates for causes of diseases with complicated inheritance patterns that affect seemingly unrelated functions. The elucidation of genetic mechanisms regulating pre-mRNA processing, combined with the development of drugs targeted at consensus RNA sequences and/or corresponding proteins, can lead to novel diagnostic and therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12489991     DOI: 10.1089/104454902320908450

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  21 in total

1.  A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization.

Authors:  Ying-Hong Feng; Xin Li; Liqin Wang; Lingying Zhou; George I Gorodeski
Journal:  J Biol Chem       Date:  2006-04-18       Impact factor: 5.157

2.  ASD: the Alternative Splicing Database.

Authors:  T A Thanaraj; Stefan Stamm; Francis Clark; Jean-Jack Riethoven; Vincent Le Texier; Juha Muilu
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

3.  Splicing factor hSlu7 contains a unique functional domain required to retain the protein within the nucleus.

Authors:  Noam Shomron; Mika Reznik; Gil Ast
Journal:  Mol Biol Cell       Date:  2004-06-04       Impact factor: 4.138

4.  SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations.

Authors:  Lei Gao; Junning Wang; Yingzi Wang; Athena Andreadis
Journal:  Mol Cell Neurosci       Date:  2006-11-29       Impact factor: 4.314

5.  Expression of two novel alternatively spliced COL2A1 isoforms during chondrocyte differentiation.

Authors:  Audrey McAlinden; Brian Johnstone; John Kollar; Najam Kazmi; Thomas M Hering
Journal:  Matrix Biol       Date:  2007-10-18       Impact factor: 11.583

6.  Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL.

Authors:  J R Leeman; M A Weniger; T F Barth; T D Gilmore
Journal:  Oncogene       Date:  2008-08-11       Impact factor: 9.867

7.  Functional diversity of human protein kinase splice variants marks significant expansion of human kinome.

Authors:  Krishanpal Anamika; Nicolas Garnier; Narayanaswamy Srinivasan
Journal:  BMC Genomics       Date:  2009-12-22       Impact factor: 3.969

8.  Regulation of alternative splicing of tau exon 10 by 9G8 and Dyrk1A.

Authors:  Shaohong Ding; Jianhua Shi; Wei Qian; Khalid Iqbal; Inge Grundke-Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  Neurobiol Aging       Date:  2011-01-06       Impact factor: 4.673

9.  Evolution of the exon-intron structure and alternative splicing of the MAGE-A family of cancer/testis antigens.

Authors:  Irena I Artamonova; Mikhail S Gelfand
Journal:  J Mol Evol       Date:  2004-11       Impact factor: 2.395

10.  Conservation of human alternative splice events in mouse.

Authors:  T A Thanaraj; Francis Clark; Juha Muilu
Journal:  Nucleic Acids Res       Date:  2003-05-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.